biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > How Profound!

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Jul 27, 2022 9:00pm

107 Views

Post# 34855636

RE:How Profound!

beenthere, thou guru, speculation remains speculation until facts resolve the speculation. A dearth of facts is always present with speculation. If the facts were known, Bioasis would be fully resolved and there would be no investing opportunity to it.

Don't make such a petty fool of yourself.

jd

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec